Ambulatory Blood Pressure Monitoring (ABPM) Task

An Ambulatory Blood Pressure Monitoring (ABPM) Task is a blood pressure monitoring task that is ambulatory monitoring (monitors at regular intervals).

• Context:
  • It can (typically) be performed with an ABPM Device.
  • It can range from being a Time-Interval ABPM Task to being a Continuous ABPM Task.
  • …
• Example(s):
  • …
• Counter-Example(s):
  • Ambulatory Electrical Heart Monitoring.
• See: White Coat Hypertension, Blood Pressure.

---

---

References

2022

• (Wikipedia, 2022) ⇒ https://en.wikipedia.org/wiki/Ambulatory_blood_pressure Retrieved:2022-8-13.
  • Ambulatory blood pressure monitoring (ABPM) measures blood pressure at regular intervals. It is believed to be able to reduce the white coat hypertension effect in which a patient's blood pressure is elevated during the examination process due to nervousness and anxiety caused by being in a clinical setting. ABPM can also detect the reverse condition, masked hypertension, where the patient have normal blood pressure during the examination but uncontrolled blood pressure at home. Out-of-office measurements are highly recommended as an adjunct to office measurements by almost all hypertension organizations.

2021

• "Ambulatory Monitoring Device Market: Information by Product Type (Cardiac Event Monitor, Holter Monitor, Mobile Cardiac Telemetry Device and Implantable Cardiac Monitor), and by Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2027."
  • QUOTE: ... The increasing innovation in the wearable ambulatory monitoring device market is expected to largely affect the growth of the market during the assessment period. For instance, in May 2021, Biobeat (Israel) launched wearable continuous ambulatory blood pressure (ABPM) and chest monitoring devices. The device will enable doctors to detect disorders in the early stages and offer required treatment to the patients. ...

2014

• (Vrijens & Urquhart, 2014) ⇒ Bernard Vrijens, and John Urquhart. (2014). “Methods for Measuring, Enhancing, and Accounting for Medication Adherence in Clinical Trials.” Clinical Pharmacology & Therapeutics 95, no. 6
  • ABSTRACT: Adherence to rationally prescribed medications is essential for effective pharmacotherapy. However, widely variable adherence to protocol-specified dosing regimens is prevalent among participants in ambulatory drug trials, mostly manifested in the form of underdosing. Drug actions are inherently dose and time dependent, and as a result, variable underdosing diminishes the actions of trial medications by various degrees. The ensuing combination of increased variability and decreased magnitude of trial drug actions reduces statistical power to discern between-group differences in drug actions. Variable underdosing has many adverse consequences, some of which can be mitigated by the combination of reliable measurements of ambulatory patients’ adherence to trial and nontrial medications, measurement-guided management of adherence, statistically and pharmacometrically sound analyses, and modifications in trial design. Although nonadherence is prevalent across all therapeutic areas in which the patients are responsible for treatment administration, the significance of the adverse consequences depends on the characteristics of both the disease and the medications.

---